phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables...

FDA Drug Recall #D-0174-2025 - Class II, December 19, 2024

Recall Summary

Recall Number D-0174-2025
Classification Class II - Moderate risk
Date Initiated December 19, 2024
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hikma Injectables USA Inc
Location Dayton, NJ
Product Type Drugs

Product Description

phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25

Reason for Recall

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lot number: 243120003D, Use by Date: 03/11/2025

Other Recalls from Hikma Injectables USA Inc

Recall # Classification Product Date
D-0173-2025 Class II ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill... Dec 19, 2024
D-0480-2024 Class III Fentanyl 1000mcg/100mL (10mcg/mL) in 0.9% Sodiu... Apr 30, 2024
D-0508-2024 Class I Phenylephrine in 0.9% Sodium Chloride Injection... Apr 29, 2024

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections, all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.